CRAIG WEEKS: Open Payments
NPI 1417338245 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 42 payments from 6 companies in 2025. Trend: 2023 $506 · 2024 $365 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 20 | $436 |
| ViiV Healthcare Company | 17 | $388 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: APRETUDE, DOVATO, Yeztugo, CABENUVA, GVOKE HYPOPEN, Biktarvy, XYOSTED, Epclusa.
Industry payments across MI — which companies pay providers there.
